$2.63
0.6230.93%
Last update: Nov 10, 12:09 PM
Longeveron Inc (LGVN) Stock Price, Quote, News & History
LGVNNASDAQ
Longeveron shares fell 59% after hours after its ELPIS II trial missed its primary endpoint.
You can purchase shares of Longeveron (NASDAQ:LGVN) through any online brokerage.
Other companies in Longeveron’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Longeveron has a consensus price target of $70.00.
The stock price for Longeveron (NASDAQ: LGVN) is $2.6316 last updated November 10, 2026 at 12:09 PM EST.
There are no upcoming dividends for Longeveron.
Longeveron does not have any upcoming earnings scheduled.
There is no upcoming split for Longeveron.
Longeveron is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy...
